CIBMTR Scientific Working Committee Research Portfolio July 1, 2019

CIBMTR Scientific Working Committee Research Portfolio July 1, 2019

CIBMTR Scientific July 1, Working Committee 2019 Research Portfolio Milwaukee Campus Minneapolis Campus Medical College of Wisconsin National Marrow Donor Program/ 9200 W Wisconsin Ave, Suite C5500 Be The Match – 500 N 5th St Milwaukee, WI 53226 USA Minneapolis, MN 55401-9959 USA (414) 805-0700 (763) 406-5800 cibmtr.org CIBMTR Scientific Working Committee Research Portfolio: July 1, 2019 TABLE OF CONTENTS 1.0 OVERVIEW .................................................................................................................................................................. 1 1.1 Membership ........................................................................................................................................................... 2 1.2 Leadership .............................................................................................................................................................. 2 1.3 Productivity ............................................................................................................................................................ 3 1.4 How to Get Involved ............................................................................................................................................ 3 2.0 ACUTE LEUKEMIA WORKING COMMITTEE .................................................................................................. 6 2.1 Leadership .............................................................................................................................................................. 6 2.2 Recent Publications ............................................................................................................................................. 6 2.3 Current Studies ..................................................................................................................................................... 9 3.0 CELLULAR IMMUNOTHERAPY FOR CANCER WORKING COMMITTEE ............................................13 3.1 Leadership ............................................................................................................................................................13 3.2 Recent Publications ...........................................................................................................................................13 3.3 Current Studies ...................................................................................................................................................14 4.0 CHRONIC LEUKEMIA WORKING COMMITTEE ...........................................................................................16 4.1 Leadership ............................................................................................................................................................16 4.2 Recent Publications ...........................................................................................................................................16 4.3 Current Studies ...................................................................................................................................................19 5.0 DONOR HEALTH AND SAFETY WORKING COMMITTEE ........................................................................23 5.1 Leadership ............................................................................................................................................................23 5.2 Recent Publications ...........................................................................................................................................23 5.3 Current Studies ...................................................................................................................................................26 6.0 GRAFT SOURCES AND MANIPULATION WORKING COMMITTEE ......................................................29 6.1 Leadership ............................................................................................................................................................29 6.2 Recent Publications ...........................................................................................................................................29 6.3 Current Studies ...................................................................................................................................................32 7.0 GRAFT-VS-HOST DISEASE WORKING COMMITTEE .................................................................................35 7.1 Leadership ............................................................................................................................................................35 7.2 Recent Publications ...........................................................................................................................................35 7.3 Current Studies ...................................................................................................................................................40 8.0 HEALTH SERVICES AND INTERNATIONAL STUDIES WORKING COMMITTEE .............................42 8.1 Leadership ............................................................................................................................................................42 8.2 Recent Publications ...........................................................................................................................................42 8.3 Current Studies ...................................................................................................................................................45 9.0 IMMUNOBIOLOGY WORKING COMMITTEE ................................................................................................49 9.1 Leadership ............................................................................................................................................................49 9.2 Recent Publications ...........................................................................................................................................49 9.3 Current Studies ...................................................................................................................................................56 2019 CIBMTR Scientific Working Committee Research Portfolio TABLE OF CONTENTS 10.0 INFECTION AND IMMUNE RECONSTITUTION WORKING COMMITTEE .......................................66 10.1 Leadership ..........................................................................................................................................................66 10.2 Recent Publications ........................................................................................................................................66 10.3 Current Studies .................................................................................................................................................68 11.0 LATE EFFECTS AND QUALITY OF LIFE WORKING COMMITTEE .....................................................70 11.1 Leadership ..........................................................................................................................................................70 11.2 Recent Publications ........................................................................................................................................70 11.3 Current Studies .................................................................................................................................................76 12.0 LYMPHOMA WORKING COMMITTEE ..........................................................................................................79 12.1 Leadership ..........................................................................................................................................................79 12.2 Recent Publications ........................................................................................................................................79 12.3 Current Studies .................................................................................................................................................84 13.0 NON-MALIGNANT DISEASES WORKING COMMITTEE .........................................................................87 13.1 Leadership ..........................................................................................................................................................87 13.2 Recent Publications ........................................................................................................................................87 13.3 Current Studies .................................................................................................................................................90 14.0 PEDIATRIC CANCER WORKING COMMITTEE ..........................................................................................93 14.1 Leadership ..........................................................................................................................................................93 14.2 Recent Publications ........................................................................................................................................93 14.3 Current Studies .................................................................................................................................................94 15.0 PLASMA CELL DISORDERS AND ADULT SOLID TUMORS WORKING

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    130 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us